June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
TIE1 gene variants identified in patients with childhood glaucoma
Author Affiliations & Notes
  • Terri L Young
    Ophthalmology and Visual Sciences, University of Wisconsin System, Madison, Wisconsin, United States
  • Kristina Whisenhunt
    Ophthalmology and Visual Sciences, University of Wisconsin System, Madison, Wisconsin, United States
  • Sean Martin
    Ophthalmology and Visual Sciences, University of Wisconsin System, Madison, Wisconsin, United States
  • Yasmin Bradfield
    Ophthalmology and Visual Sciences, University of Wisconsin System, Madison, Wisconsin, United States
  • Simone Finzi
    Department of Ophthalmology, Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil
  • Stuart Tompson
    Ophthalmology and Visual Sciences, University of Wisconsin System, Madison, Wisconsin, United States
  • Footnotes
    Commercial Relationships   Terri Young None; Kristina Whisenhunt None; Sean Martin None; Yasmin Bradfield None; Simone Finzi None; Stuart Tompson None
  • Footnotes
    Support  Research To Prevent Blindness, Inc., University of Wisconsin Centennial Scholars Fund
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 4352. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Terri L Young, Kristina Whisenhunt, Sean Martin, Yasmin Bradfield, Simone Finzi, Stuart Tompson; TIE1 gene variants identified in patients with childhood glaucoma. Invest. Ophthalmol. Vis. Sci. 2023;64(8):4352.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Childhood glaucoma (CG) is a rare heritable disorder, and is a major category for childhood blindness. Uncontrolled high intraocular pressure can lead to globe enlargement, corneal expansion with clouding, and retinal ganglion cell/optic nerve damage causing impaired vision and possible blindness. To date, genetic studies explain just over half of the disease etiology. We sought to identify novel molecular causes of CG in a cohort of families with no known gene variants.

Methods : Once consented with approved human subjects protocols, medical histories and samples for DNA extraction were obtained from patient subjects. Exome sequencing was performed on the affected probands using Sure Select Human All Exon capture kit (version 5/6) or Twist exome (34 MB capture target) on an Illumina HiSeq 2000/2500 or NovaSeq 6000 platform, respectively. Sequence analysis was performed using Golden Helix SVS software. Variants that were non-coding, synonymous, or with an allele frequency greater than 0.002 (gnomAD population datasets) were removed. Variants in probands were confirmed and genotypes of available family members were identified via Sanger sequencing.

Results : Three families of 78 were identified with heterozygous TIE1 variants (p.Glu172Lys, p.Arg279Gln, p.Ile1046Thr). Global and ethnically matched population allele counts were low for all variants. Protein sequence alignments from 100 vertebrates showed conservation of the reference residues. All variants were predicted to be detrimentally affected functionally by in silico programs MutationTaster, FATHMM, and CADD.

Conclusions : Herein, we present the first reported human variants in TIE1 associated with childhood glaucoma. TIE1 is a transmembrane protein required for the development, integrity, and survival of vascular endothelial cells, and is strongly expressed in Schlemm’s canal (SC). SC is an endothelial-lined structure with characteristics of both lymphatic and blood vessels, and its development is essential for aqueous humor drainage. Mice lackingTie1 develop an aberrant SC, resulting in impaired aqueous humor outflow with consequent increase in intraocular pressure. We propose that heterozygous variants in TIE1 are a potential cause of autosomal dominant CG, similar to its associated pathway members TEK (TIE2) and ANGPT1.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×